Molinoff PB - Search Results

1

Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.

Franco A, Dang X, Zhang L, Molinoff PB, Dorn GW 2nd. Franco A, et al. Among authors: molinoff pb. J Pharmacol Exp Ther. 2022 Nov;383(2):137-148. doi: 10.1124/jpet.122.001332. Epub 2022 Sep 2. J Pharmacol Exp Ther. 2022. PMID: 36507849 Free PMC article.

2

Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.

Rosen RC, Diamond LE, Earle DC, Shadiack AM, Molinoff PB. Rosen RC, et al. Among authors: molinoff pb. Int J Impot Res. 2004 Apr;16(2):135-42. doi: 10.1038/sj.ijir.3901200. Int J Impot Res. 2004. PMID: 14999221 Clinical Trial.

3

Common to both academia and industry: the challenge of discovery. An interview with Perry Molinoff.

Molinoff PB. Molinoff PB. Mol Interv. 2001 Jun;1(2):78-83. Mol Interv. 2001. PMID: 14993327

4

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.

Diamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB. Diamond LE, et al. Among authors: molinoff pb. Int J Impot Res. 2004 Feb;16(1):51-9. doi: 10.1038/sj.ijir.3901139. Int J Impot Res. 2004. PMID: 14963471 Clinical Trial.

5

Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.

Nakai S, Hirose T, Uwahodo Y, Imaoka T, Okazaki H, Miwa T, Nakai M, Yamada S, Dunn B, Burris KD, Molinoff PB, Tottori K, Altar CA, Kikuchi T. Nakai S, et al. Among authors: molinoff pb. Eur J Pharmacol. 2003 Jul 4;472(1-2):89-97. doi: 10.1016/s0014-2999(03)01857-0. Eur J Pharmacol. 2003. PMID: 12860477

6

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. Molinoff PB, et al. Ann N Y Acad Sci. 2003 Jun;994:96-102. doi: 10.1111/j.1749-6632.2003.tb03167.x. Ann N Y Acad Sci. 2003. PMID: 12851303 Clinical Trial.

7

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Burris KD, et al. Among authors: molinoff pb. J Pharmacol Exp Ther. 2002 Jul;302(1):381-9. doi: 10.1124/jpet.102.033175. J Pharmacol Exp Ther. 2002. PMID: 12065741

8

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW. Gribkoff VK, et al. Among authors: molinoff pb. Nat Med. 2001 Apr;7(4):471-7. doi: 10.1038/86546. Nat Med. 2001. PMID: 11283675

9

Characterization of 5-HT- and ionomycin-stimulated changes in levels of intracellular calcium and PI hydrolysis in P11 cells.

Wohlpart KL, Molinoff PB. Wohlpart KL, et al. Among authors: molinoff pb. Ann N Y Acad Sci. 1998 Dec 15;861:240-1. doi: 10.1111/j.1749-6632.1998.tb10199.x. Ann N Y Acad Sci. 1998. PMID: 9928265 No abstract available.

10

Regulation of levels of 5-HT2A receptor mRNA.

Wohlpart KL, Molinoff PB. Wohlpart KL, et al. Among authors: molinoff pb. Ann N Y Acad Sci. 1998 Dec 15;861:128-35. doi: 10.1111/j.1749-6632.1998.tb10183.x. Ann N Y Acad Sci. 1998. PMID: 9928249 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page